Pulmonary Arterial Hypertension Worsened by Bosutinib in Patient With Previous Dasatinib Treatment

被引:1
|
作者
Parthvi, Rukma [1 ]
Gibbons, William [1 ]
机构
[1] SUNY Buffalo, Div Pulm & Crit Care, Buffalo, NY 14260 USA
关键词
INHIBITOR; DETERIORATION; THERAPY;
D O I
10.1097/MJT.0000000000001156
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:E704 / E706
页数:3
相关论文
共 50 条
  • [1] A case of worsening pulmonary arterial hypertension and pleural effusions by bosutinib after prior treatment with dasatinib
    Seegobin, Karan
    Babbar, Amit
    Ferreira, Jason
    Lyons, Brittany
    Cury, James
    Seeram, Vandana
    PULMONARY CIRCULATION, 2017, 7 (04) : 808 - 812
  • [2] Recurrent Pleural Effusions and Evidence of Pulmonary Arterial Hypertension on Bosutinib in a CML Patient Previously Treated With Dasatinib Therapy
    Beale, P.
    Hourigan, E. K.
    Collins, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [4] Pulmonary arterial hypertension in a patient treated with dasatinib: A case report
    Skride A.
    Sablinskis M.
    Sablinskis K.
    Lesina K.
    Lejnieks A.
    Lejniece S.
    Journal of Medical Case Reports, 11 (1)
  • [5] Incident pulmonary arterial hypertension associated with Bosutinib
    Yo, Shaun
    Thenganatt, John
    Lipton, Jeffrey
    Granton, John
    PULMONARY CIRCULATION, 2020, 10 (03)
  • [6] Bosutinib-induced Pulmonary Arterial Hypertension in a Patient with Chronic Myelogenous Leukemia
    Kahn, M.
    Seo, J.
    Kyung, S. R.
    Barot, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [8] Dasatinib (Sprycel) and pulmonary arterial hypertension
    不详
    AUSTRALIAN PRESCRIBER, 2012, 35 (02) : 68 - 68
  • [10] Successful treatment with nilotinib after bosutinib-induced pulmonary arterial hypertension recurrence following dasatinib in chronic myeloid leukemia in chronic phase
    Takatsuka, Ibuki
    Hirata, Hiroya
    Takahashi, Takumi
    Dohtan, Satoshi
    Oka, Shinichiro
    Sakamoto, Nami
    Takaba, Masamitsu
    Adachi, Miwa
    Takemura, Tomonari
    Nagata, Yasuyuki
    Ono, Takaaki
    LEUKEMIA RESEARCH REPORTS, 2022, 17